Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Renovorx, Inc. (RNXT)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 8,380,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for its lead product candidate RenovoGem™. Co.'s therapy platform, RenovoRx Trans-Arterial Micro-Perfusion, or RenovoTAMP™ utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 172,128 173,228 173,228 178,728
Total Buy Value $0 $1,151 $1,151 $12,426
Total People Bought 5 6 6 6
Total Buy Transactions 5 6 6 7
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 14
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Macfarlane Kirsten Angela Director   –       •      –    2024-01-26 4 B $0.00 $0 D/D 40,983 40,983 2.31     -
   Marton Laurence Director   –       •      –    2024-01-26 4 B $0.00 $0 D/D 8,196 33,634 2.31     -
   Agah Ramtin Chief Medical Officer   •       •      –    2024-01-26 4 B $0.00 $0 D/D 40,983 47,460 2.73     -
   Spiegel Robert J. Director   –       •      –    2024-01-26 4 B $0.00 $0 D/D 40,983 40,983 2.31     -
   Bagai Shaun Chief Executive Officer   •       •      –    2024-01-26 4 B $0.00 $0 D/D 40,983 292,540 2.73     -
   Nelms Angela Chief Operating Officer   •       –      –    2023-10-03 4 B $1.05 $1,151 D/D 1,100 1,100 2.66     -
   Marton Laurence Director   –       •      –    2022-11-03 4 OE $1.70 $43,245 D/D 25,438 25,438     -
   Bagai Shaun Chief Executive Officer   •       •      –    2022-05-19 4 B $2.05 $11,275 D/D 5,500 251,557 2.81     -
   Bank Of The West 10% Owner   –       –       •   2022-03-16 3 IO $0.00 $0 I/I 0 975,000     -
   Agah Ramtin Chief Medical Officer   •       •       •   2021-08-30 4 A $0.00 $0 D/D 1,295 976,295     -
   Manners Paul Chief Financial OfficerOfficer   •       –      –    2021-08-25 3 IO $0.00 $0 D/D 0 23,333     -
   Najmabadi Family Trust Dated April 22, 2021 10% Owner   –       –       •   2021-08-25 3 IO $0.00 $0 I/I 0 975,000     -
   Najmabadi Family Trust Dated April 22, 2021 10% Owner   –       –       •   2021-08-25 3 IO $0.00 $0 D/D 0 10,000     -
   Agah Ramtin Chief Medical OfficerOfficer   •       •       •   2021-08-25 3 IO $0.00 $0 D/D 0 975,000     -

  14 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed